Skip to main content

LPT 25 mg Pill: brown, capsule/oblong

The pill with imprint LPT 25 mg (Brown, Capsule/Oblong, 0mm) has been identified as Topiramate Extended-Release 25 mg and is used for Lennox-Gastaut Syndrome, Migraine Prevention, Epilepsy, Seizure Prevention, and Seizures. It belongs to the drug class carbonic anhydrase inhibitor anticonvulsants and is not a controlled substance.

Images for LPT 25 mg

Topiramate Extended-Release

Imprint
LPT 25 mg
Strength
25 mg
Color
Brown (opaque light brown)
Shape
Capsule/Oblong (capsule)
Availability
Prescription only
Drug Class
Carbonic anhydrase inhibitor anticonvulsants
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Vitruvias Therapeutics, Inc.
National Drug Code (NDC)
69680-0177

Get help with Imprint Code FAQs.

Related images for "LPT 25 mg"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.